Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Search help
2,886 results
  1. Non-Small Cell Lung Cancer Treatment (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK65865
    ... vinorelbine plus cisplatin for first-line treatment of advanced nonsmall cell lung carcinoma (TAX 326). Cancer 104 (12): 2766-74, 2005. [ ... or mitomycin, vinblastine, and cisplatin in patients with advanced nonsmall cell lung carcinoma. Cancer 98 (3): 542-53, 2003. [ PubMed : 12879472 ] ...
  2. List of Excluded Studies - Diagnosis and Management of Metastatic Malignant Disease of Unknown Primary Origin - NCBI ... 
    https://www.ncbi.nlm.nih.gov/books/NBK82161
    ... from adenocarcinoma. [ PubMed : 9426522 ] Parini CL. Occult metastatic lung carcinoma presenting as locally advanced uterine carcinosarcoma on positron emission tomography/computed tomography ...
  3. NLM Digital Collections - Management of lung cancer : a national clinical guideline 
    Publication: Edinburgh, Scotland : Scottish Intercollegiate Guidelines Network (SIGN), February 2014
    resource.nlm.nih.gov/101671102
    ... 97(2):177-86. per two fractions) in advanced non-small-cell lung carcinoma is comparable to standard fractionation for symptom control ... vincristine (CAV)/cisplatin and etoposide (PVP) treatment of advanced non-small-cell lung cancer. J Clin Oncol ... long term follow-up. Cancer 1998; ...
  4. pdf2019NewMeShHeadingsSingleColumn.pdf 
    https://www.nlm.nih.gov/.../2019NewMeShHeadingsSingleColumn.pdf
    ... It is also used in the treatment of advanced or recurring NON-SMALL CELL LUNG CANCER; RENAL CELL CARCINOMA; and HODGKIN'S LYMPHOMA. Tree locations: Antibodies, Monoclonal, Humanized ...
  5. Cannabis and Cannabinoids (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK65755
    ... nivolumab immunotherapy.[ 10 ] One hundred forty patients with advanced melanoma, non-small cell lung cancer, and renal cell carcinoma received the checkpoint inhibitor nivolumab (89 patients received ...
  6. pdf2019NewMeShHeadings.pdf 
    https://www.nlm.nih.gov/mesh/2019/download/2019NewMeShHeadings.pdf
    ... It is also used in the treatment of advanced or recurring NON-SMALL CELL LUNG CANCER; RENAL CELL CARCINOMA; and HODGKIN'S LYMPHOMA. Parent Heading: Antibodies, Monoclonal, Humanized ...
  7. NLM Digital Collections - Master protocols : efficient clinical trial design strategies to expedite development of ... 
    Publication: Silver Spring, MD : Center for Drug Evaluation and Research, March 2022
    resource.nlm.nih.gov/9918452088706676
    ... substudy, biomarker-driven trial in human subjects with advanced/metastatic squamous cell carcinoma of the lung where docetaxel was the common control arm in ...
  8. Cartilage (Bovine and Shark) (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK65762
    ... retrospective analysis), and patients with refractory renal cell carcinoma (prospective analysis) Unknown None f [ 9 ] Phase I/II trial Advanced non-small cell lung cancer AT-941/Neovastat (shark) 80; None No ...
  9. Nasopharyngeal Carcinoma Treatment (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK65750
    ... and metastatic spread, such as that found in lung or skeletal metastases in patients with advanced nasopharyngeal carcinoma.[ 6 ] If a patient has a relapse, a ...
  10. What is the expected value of perfect information in reducing uncertainty surrounding the cost-effectiveness of ... 
    https://www.ncbi.nlm.nih.gov/books/NBK82153
    ... of care in a trial of chemotherapy for advanced non-small cell lung cancer. Lung Cancer (01695002). 2002; 37 (2):219. [ PubMed : 12140146 ] Briasoulis E, et al. Carboplatin plus paclitaxel in unknown primary carcinoma: a phase II Hellenic Cooperative Oncology Group Study. ...
first · previous · 1 · 2 · 3 · 4 · 5 · 6 · 7 · 8 · 9 · 10 · next · last